FindTrial
Sign In

Usefulness of the Chronic Obstructive Pulmonary Disease-population (COPD-PS) Questionnaire and the COPD-6 Device in the Chronic Obstructive Pulmonary Disease Detection in a Tobacco Detoxication Consultation

Usefulness of the Chronic Obstructive Pulmonary Disease-population (COPD-PS) Questionnaire and the COPD-6 Device in the Chronic Obstructive Pulmonary Disease Detection in a Tobacco Detoxication Consultation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04121117
Enrollment
245
Registered
2019-10-09
Start date
2019-10-15
Completion date
2020-06-15
Last updated
2019-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic obstructive pulmonary disease, COPD, Chronic obstructive pulmonary disease population questionnaire, COPD-PS, COPD-6

Brief summary

The aim of this study is to evaluate the usefulness of the chronic obstructive pulmonary disease-population questionnaire (COPD-PS) and the COPD-6 device in the early detection of chronic obstructive pulmonary disease in smoker patients .

Interventions

OTHERChronic obstructive pulmonary disease screening

To verify the tobacco withdrawal, the patients will make a cooximetry. For the detection of a possible obstructive pattern a measurement of the ventilatory capacity will be make using the COPD-6 device and for the confirmation of COPD diagnosis and the assesment of the airflow obstruction severity a spirometry will be make. The patients will also complete the COPD-PS questionnaire.

Sponsors

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 35 years old * Accumulative tobacco rate \> 10 paq-year that go to the tobacco detoxication consultation

Exclusion criteria

* Unable to fulfill the questionnarie * Unable to adequately perform the COPD-6 or forced spirometry maneuvers included in the study. * Reject to participate and sign the informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the usefulness in the COPD early detection of the combination of the COPD-PS questionnaire and the COPD-6 device.Up to 12 months after the first consultationVerify if the combination of the COPDS-questionnaire (made of different items that allow the detection of chronic airflow obstruction) and the COPD-6 device (tool that measures the ventilatory capacity) is suitable for the COPD early detection.

Countries

Spain

Contacts

Primary ContactAgustín Valido Morales
agustins.valido.sspa@juntadeandalucia.es955 00 80 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026